|Bid||325.05 x 1000|
|Ask||369.11 x 900|
|Day's Range||347.60 - 351.14|
|52 Week Range||250.21 - 351.86|
|Beta (5Y Monthly)||1.05|
|PE Ratio (TTM)||38.30|
|Earnings Date||Jul. 22, 2020 - Jul. 27, 2020|
|Forward Dividend & Yield||0.88 (0.25%)|
|Ex-Dividend Date||Jun. 12, 2020|
|1y Target Est||357.13|
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
On coronavirus-led global supply chain disruption, Thermo Fisher (TMO) records a decline in its quarterly Analytical Instruments revenues.
Thermo Fisher (TMO) delivered earnings and revenue surprises of 5.38% and 0.38%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, NY / ACCESSWIRE / April 22, 2020 / Thermo Fisher Scientific, Inc. (NYSE:TMO) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on April 22, 2020 at ...
Investing.com - Thermo Fisher Scientific (NYSE:TMO) reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ford has expanded its plan to produce critical medical equipment and supplies, including a new effort to make reusable gowns from airbag materials as well as a partnership with scientific instrument provider Thermo Fisher Scientific to ramp up production of COVID-19 collection kits to test for the virus. This broader plan highlights the latest effort by automakers and medical device manufacturers to help ease a shortage of equipment and supplies such as face shields, face masks, protective gowns and ventilators, a medical device that is used in the treatment of COVID-19, a disease caused by the coronavirus. Ford announced in March a partnership with 3M to build Powered Air-Purifying Respirators (PAPRs), as well as a separate effort to produce more than 3 million face shields at its factory in Plymouth, Mich.
It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols, resource allocation and drafting the right healthcare policies.
Reuters has learned Amazon.com is in touch with two coronavirus test makers as it considers how to screen its staff and reduce infection risks at its warehouses. Internal meeting notes seen by Reuters say the online retailer is talking to CEOs at Abbott Laboratories and Thermo Fisher Scientific. The CEOs said they'd like to work with Amazon but said their testing capacity is taken up by the U.S. government. The documents also say talks touched upon whether Amazon could start such tests in at least one warehouse near its Seattle headquarters. In a statement Saturday, Abbott confirmed it has been contacted by Amazon and other companies to provide testing for their workforces. Thermo Fisher did not respond to a request for comment, and Amazon declined to comment. The drive to increase screening measures come as Amazon faces protests at several warehouses, where employees say they increasingly fear they'll contract the coronavirus at work. The company plans to roll out temperature checks and face masks for workers at all its U.S. and European warehouses by early next week. In the longer term, the notes say, Amazon wants to test workers for the virus and hopes other companies will follow suit.
The chief executives of Abbott Laboratories <ABT.N> and Thermo Fisher Scientific Inc <TMO.N> have told Amazon they would like to work with the e-commerce company, though the U.S. government is taking up all of their testing capacity at present, the notes said. The nature of Amazon's conversations with the test makers and the exact assistance they might offer were unclear. The document separately indicated Amazon is looking into the ability to screen more than one person at a time for the virus, and it also wants to partner with a medical organization in its testing efforts.
Following the announcement of the agreement to pass the historic stimulus bill, we look into four MedTech stocks that stand to gain from the same.